Equitable access to direct-acting antivirals: Canada's path to a hepatitis C-free tomorrow.
| Autor: | Canani F; School of Nursing, York University, Toronto, Canada., Feld JJ; Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Canada., Biondi MJ; School of Nursing, York University, Toronto, Canada.; Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Canada. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Canadian liver journal [Can Liver J] 2024 Feb 26; Vol. 7 (1), pp. 3-4. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024). |
| DOI: | 10.3138/canlivj-2023-0038 |
| Abstrakt: | Competing Interests: MJ Biondi reports receiving research support and consulting fees from AbbVie, Gilead, Abbott, Specialty Rx Solutions, and McKesson Canada. JJ Feld reports receiving research support and consulting fees from AbbVie and Gilead. No other competing interests were declared. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|